3rd International Congress on Clinical Trials in Oncology & Hemato-Oncology (ICTO 2019)

Topics

• Personalized cancer medicine
• Design of clinical trials in the new era
• Monitoring of Trials and Statistics
• Immuno-oncology - End Point with Immunotherapy
• Phase 4 Trials
• Regulations – Survival based Medicine
• Ethics and Patients’ Rights
• Expanded access trials
• How to design a Clinical Trial
• Healthcare economy
• Side Effects
• End Point with Immunotherapy

Who should Attend

• Clinical Trial Pharmacists and Investigators
• Study Coordinators
• Hematologists
• Pediatric Clinical Trial Oncologists
• R&D personnel
• Medical Professionals
• CROs / CRAs
• Regulatory Affairs Specialists
• Research Facility Managers
• QA personnel
• Pharmaceutical Company Representatives